201 related articles for article (PubMed ID: 35516454)
1. Melanoma Molecular Subtypes and Development of Prognostic and Immunotherapy-Related Genetic Characteristics by Ferroptosis Gene Analysis.
Xu L; Zhang Y; Liu T; Wang L; Zhao Z; Zhang X; Li X; Wu W; Yu S
Comput Math Methods Med; 2022; 2022():2992939. PubMed ID: 35516454
[TBL] [Abstract][Full Text] [Related]
2. Exploring a 7-gene prognostic model based on ferroptosis for efficiently guiding immunotherapy in melanoma patients.
Zhang X; Ding C; Zhao Z
Adv Med Sci; 2022 Sep; 67(2):364-378. PubMed ID: 36155341
[TBL] [Abstract][Full Text] [Related]
3. Identification and validation of ferroptosis-related lncRNA signature as a prognostic model for skin cutaneous melanoma.
Guo S; Chen J; Yi X; Lu Z; Guo W
Front Immunol; 2022; 13():985051. PubMed ID: 36248853
[TBL] [Abstract][Full Text] [Related]
4. Analysis on tumor immune microenvironment and construction of a prognosis model for immune-related skin cutaneous melanoma.
Wu M; Wang Z; Zhang J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 May; 48(5):671-681. PubMed ID: 37539569
[TBL] [Abstract][Full Text] [Related]
5. Integrative lactylation and tumor microenvironment signature as prognostic and therapeutic biomarkers in skin cutaneous melanoma.
Zhu Y; Song B; Yang Z; Peng Y; Cui Z; Chen L; Song B
J Cancer Res Clin Oncol; 2023 Dec; 149(20):17897-17919. PubMed ID: 37955686
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of an immune gene set-based prognostic signature in cutaneous melanoma.
Tian Q; Gao H; Zhao W; Zhou Y; Yang J
Future Oncol; 2021 Nov; 17(31):4115-4129. PubMed ID: 34291650
[TBL] [Abstract][Full Text] [Related]
7. A new ferroptosis-related genetic mutation risk model predicts the prognosis of skin cutaneous melanoma.
He J; Huang W; Li X; Wang J; Nie Y; Li G; Wang X; Cao H; Chen X; Wang X
Front Genet; 2022; 13():988909. PubMed ID: 36685905
[No Abstract] [Full Text] [Related]
8. Genes associated with cellular senescence favor melanoma prognosis by stimulating immune responses in tumor microenvironment.
Liang X; Lin X; Lin Z; Lin W; Peng Z; Wei S
Comput Biol Med; 2023 May; 158():106850. PubMed ID: 37031510
[TBL] [Abstract][Full Text] [Related]
9. A Necroptosis-Related Gene Signature to Predict the Prognosis of Skin Cutaneous Melanoma.
Xie Y; Xu Z; Mei X; Shi W
Dis Markers; 2022; 2022():8232024. PubMed ID: 36438905
[TBL] [Abstract][Full Text] [Related]
10. The fatty acid-related gene signature stratifies poor prognosis patients and characterizes TIME in cutaneous melanoma.
Hua S; Wang W; Yao Z; Gu J; Zhang H; Zhu J; Xie Z; Jiang H
J Cancer Res Clin Oncol; 2024 Jan; 150(2):40. PubMed ID: 38279987
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of ferroptosis-related lncRNA signature and immune-related gene signature for predicting the prognosis of cutaneous melanoma patients.
Xiong K; Wang Z; Hounye AH; Peng L; Zhang J; Qi M
Apoptosis; 2023 Jun; 28(5-6):840-859. PubMed ID: 36964478
[TBL] [Abstract][Full Text] [Related]
12. Ferroptosis-related genes are candidate diagnostic and prognostic biomarkers for skin cutaneous melanoma.
Jing HY; Gu W; Tan XY; Ma YR
Biomark Med; 2022 Feb; 16(3):179-196. PubMed ID: 35057634
[TBL] [Abstract][Full Text] [Related]
13. Ferroptosis-Related Gene Signature Predicts the Prognosis of Skin Cutaneous Melanoma and Response to Immunotherapy.
Xu Z; Xie Y; Mao Y; Huang J; Mei X; Song J; Sun Y; Yao Z; Shi W
Front Genet; 2021; 12():758981. PubMed ID: 34804126
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation of TME-related signatures to predict prognosis and response to anti-tumor therapies in skin cutaneous melanoma.
Lian W; Zheng X
Funct Integr Genomics; 2023 May; 23(2):153. PubMed ID: 37160578
[TBL] [Abstract][Full Text] [Related]
15. The Landscape of the Tumor Microenvironment in Skin Cutaneous Melanoma Reveals a Prognostic and Immunotherapeutically Relevant Gene Signature.
Zhou S; Sun Y; Chen T; Wang J; He J; Lyu J; Shen Y; Chen X; Yang R
Front Cell Dev Biol; 2021; 9():739594. PubMed ID: 34660598
[TBL] [Abstract][Full Text] [Related]
16. Analysis of differential gene immune infiltration and clinical characteristics of skin cutaneous melanoma based on systems biology and drug repositioning methods to identify drug candidates for skin cutaneous melanoma.
Long S; Xu J; Huang H
Naunyn Schmiedebergs Arch Pharmacol; 2023 Oct; 396(10):2427-2447. PubMed ID: 37086280
[TBL] [Abstract][Full Text] [Related]
17. Construction of a Ferroptosis-Related Gene Signature for Predicting Survival and Immune Microenvironment in Melanoma Patients.
Zeng N; Ma L; Cheng Y; Xia Q; Li Y; Chen Y; Lu Z; Lu Q; Jiang F; Luo D
Int J Gen Med; 2021; 14():6423-6438. PubMed ID: 34675611
[TBL] [Abstract][Full Text] [Related]
18. A Novel Ferroptosis-Related lncRNA Prognostic Model and Immune Infiltration Features in Skin Cutaneous Melanoma.
Sun S; Zhang G; Zhang L
Front Cell Dev Biol; 2021; 9():790047. PubMed ID: 35186949
[No Abstract] [Full Text] [Related]
19. Comprehensive analysis of ferroptosis-related genes and prognosis of cutaneous melanoma.
Liu C; Liu Y; Yu Y; Zhao Y; Yu A
BMC Med Genomics; 2022 Mar; 15(1):39. PubMed ID: 35232428
[TBL] [Abstract][Full Text] [Related]
20. Identification and validation of a ferroptosis-related gene signature for predicting survival in skin cutaneous melanoma.
Ping S; Wang S; Zhao Y; He J; Li G; Li D; Wei Z; Chen J
Cancer Med; 2022 Sep; 11(18):3529-3541. PubMed ID: 35373463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]